LGALS2 and neoplasm: Five genes were identified as potential regulators of immune surveillance in all screening settings, among which galectin 2 (Lgals2) induced the increased number of tumor-associated macrophages and resulted in the immunosuppressive microenvironment (Ji et al., 2022).